Catalyst Financial Partners LLC Merck & Co., Inc. Transaction History
Catalyst Financial Partners LLC
- $511 Billion
- Q3 2024
A detailed history of Catalyst Financial Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Catalyst Financial Partners LLC holds 16,960 shares of MRK stock, worth $1.73 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
16,960
Previous 17,695
4.15%
Holding current value
$1.73 Million
Previous $2.19 Billion
12.08%
% of portfolio
0.38%
Previous 0.48%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,805Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.38 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.81 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $258B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...